Paper29929902
Prostate sparing cystectomy for bladder cancer: A two-center study.
Voskuilen CS and 12 others. Eur J Surg Oncol, 2018. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Prostate sparing cystectomy for bladder cancer: A two-center study. Papers, record 29929902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29929902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystectomy | Major topic |
| Forecasting | Major topic |
| Organ Sparing Treatments | Major topic |
| Penile Erection | Major topic |
| Prostate | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Urination | Major topic |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Recurrence, Local | |
| Prospective Studies | |
| Treatment Outcome |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41244901 | Efficacy and safety of male fertility-sparing radical cystectomy with orthotopic neobladder versus radical cystectomy and nerve-sparing cystectomy: a meta-analysis. | Front Oncol | 2025 | https://conductscience.org/library/papers/41244901 | PubMed |
| 40916004 | Prostate sparing radical cystectomy and neobladder: institutional long-standing qualified consideration. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/40916004 | PubMed |
| 40777088 | Long-term follow-up results of prostate capsule-sparing and nerve-sparing radical cystectomy with neobladder: a single-center retrospective analysis. | Front Urol | 2024 | https://conductscience.org/library/papers/40777088 | PubMed |
| 39765339 | Long-term Outcomes of Prostate Capsule-Sparing and Nerve-Sparing Radical Cystectomy With Neobladder: A Propensity Score-Matched Comparison. | Int Neurourol J | 2024 | https://conductscience.org/library/papers/39765339 | PubMed |
| 39488630 | Oncological outcomes of organ-sparing cystectomy versus standard radical cystectomy in male patients diagnosed with bladder cancer. | World J Urol | 2024 | https://conductscience.org/library/papers/39488630 | PubMed |
| 38184830 | Incidental carcinoma of the prostate in cystoprostatectomy specimens - is it always a toothless lion? | Rom J Morphol Embryol | 2023 | https://conductscience.org/library/papers/38184830 | PubMed |
| 36816151 | Oncological and functional outcomes of organ-preserving cystectomy versus standard radical cystectomy: A systematic review and meta-analysis. | BJUI Compass | 2023 | https://conductscience.org/library/papers/36816151 | PubMed |
| 36057019 | Cystectomy for Benign Indications. | Curr Urol Rep | 2022 | https://conductscience.org/library/papers/36057019 | PubMed |
| 32493286 | Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence. | BMC Urol | 2020 | https://conductscience.org/library/papers/32493286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29929902
GET https://conductscience.org/api/papers/v1/29929902/authors